Landmark international study: CAR T-cell therapy safe and effective in youth with leukemia

Published: 31/01/2018
Landmark international study: CAR T-cell therapy safe and effective in youth with leukemia
Source: WWW.EUREKALERT.ORG

Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published today in the New England Journal of Medicine. Senior authors on the study include Stephen A. Grupp, of Children's Hospital of Philadelphia and Michael A. Pulsipher, M.D., of Children's Hospital Los Angeles (CHLA).

Read more
Related news
Comment
FACEBOOK